7/31/2013

Pharmaceutical researchers are studying a mutation in the SCN9A gene that makes patients immune to pain. While medications can mute pain, new experimental formulations that try to mimic the gene mutation aim to stop nerve cells from sending pain signals to the brain.

Related Summaries